Document Detail


Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants.
MedLine Citation:
PMID:  15155869     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recent evidence strongly implicates the inflammatory response to intrauterine infection in the pathogenesis of neonatal brain and lung injury. We hypothesized that lung and brain injury in preterm infants occurs during a common developmental window of vulnerability as the result of an inflammatory response in different compartments. To determine whether inflammatory markers in these compartments are associated with bronchopulmonary dysplasia (BPD) or cranial ultrasound (CUS) abnormalities in infants <33 wk gestation age (GA) and <1501 g birth weight, we analyzed placental pathology and serum and cerebrospinal fluid (CSF) IL-6, IL-1beta, and tumor necrosis factor-alpha (TNF-alpha) concentrations in 276 infants. Logistic regressions were performed stratified by GA. Histologic chorioamnionitis was significantly associated with BPD in infants </=28 wk GA (OR 3.6, p = 0.027). Maternal stage of chorioamnionitis significantly correlated with severity of BPD. Presence of a fetal inflammatory response indicated by fetal vasculitis or elevated cytokines was not associated with the development of BPD. Serum IL-6 >/=17 pg/mL was associated with an abnormal CUS in infants >28 wk GA (OR 3.36, p = 0.023) but not </=28 wk GA. CSF concentrations of IL-6 >/=6.5 pg/mL and TNF-alpha >/=3 pg/mL were associated with abnormal CUS in infants </=28 wk GA (IL-6 OR 3.0; TNF-alpha OR 3.5; p < 0.05 each case) but not >/=28 wk GA. These data suggest that in infants </=28 wks GA, BPD may be initiated by inflammatory mediators in amniotic fluid, but brain injury may involve variations in the systemic inflammatory response.
Authors:
Rose M Viscardi; Catherine K Muhumuza; Andres Rodriguez; Karen D Fairchild; Chen-Chih J Sun; George W Gross; Andrew B Campbell; P David Wilson; Lisa Hester; Jeffrey D Hasday
Related Documents :
21901679 - Diuretics acting on the distal renal tubule for preterm infants with (or developing) ch...
17805339 - The effect of inhaled nitric oxide on pulmonary function in preterm infants.
9514139 - Evidence for the safety of ascorbic acid administration to the premature infant.
15449969 - Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.
8692619 - A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant...
8414739 - Dexamethasone treatment suppresses collagen synthesis in infants with bronchopulmonary ...
9232039 - Low birth weight and latino ethnicity. examining the epidemiologic paradox.
17519929 - Infant serotonin transporter (slc6a4) promoter genotype is associated with adverse neon...
11826199 - A longitudinal assessment of thyroid hormone concentrations in preterm infants younger ...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Pediatric research     Volume:  55     ISSN:  0031-3998     ISO Abbreviation:  Pediatr. Res.     Publication Date:  2004 Jun 
Date Detail:
Created Date:  2004-05-24     Completed Date:  2004-12-06     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0100714     Medline TA:  Pediatr Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1009-17     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA. rviscard@umaryland.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain Injuries / blood*,  cerebrospinal fluid*,  etiology
Bronchopulmonary Dysplasia / blood*,  cerebrospinal fluid*,  etiology
Chorioamnionitis / blood,  cerebrospinal fluid,  complications
Cohort Studies
Female
Fetal Blood / metabolism*
Humans
Infant, Newborn
Infant, Premature
Inflammation Mediators / cerebrospinal fluid,  metabolism*
Interleukin-1 / blood,  cerebrospinal fluid
Interleukin-6 / blood,  cerebrospinal fluid
Male
Pregnancy
Pregnancy Outcome
Risk Factors
Tumor Necrosis Factor-alpha / cerebrospinal fluid,  metabolism
Uterus / blood supply,  metabolism
Grant Support
ID/Acronym/Agency:
R01 HL71113-01/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Inflammation Mediators; 0/Interleukin-1; 0/Interleukin-6; 0/Tumor Necrosis Factor-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune deve...
Next Document:  Prognostic significance of amplitude-integrated EEG during the first 72 hours after birth in severel...